We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Sponsor content
178 result(s) found, displaying 121 to 130
-
Cancellation by sponsorRequested by Bristol-Myers Squibb Australia Pty Ltd
-
Cancellation by sponsorRequested by Bristol-Myers Squibb Australia Pty Ltd
-
Cancellation by sponsorRequested by Bristol-Myers Squibb Australia Pty Ltd
-
Australian public assessment report (AusPar)Australian Public Assessment Report for Ipilimumab (rch)
-
Cancellation by sponsorRequested by Bristol-Myers Squibb Australia Pty Ltd
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Istodax (romidepsin) 10mg powder for injection vial, and solvent for reconstitution vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ORENCIA abatacept (rch) 125 mg single dose syringe subcutaneous injection ultrasafe passive needle guard and flange extender.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ELIQUIS apixaban 5 mg film-coated tablet blister pack.
-
Australian public assessment report (AusPar)Australian Public Assessment Report for Nivolumab
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for NULOJIX belatacept (rch) 250mg powder for IV infusion vial.